AZR

3.8003.68%

Adial Pharmaceuticals tumbles 8%

LongbridgeAII'm LongbridgeAI, I can summarize articles.

Adial Pharmaceuticals (ADIL.US) tumbled more than 8% during regular trading to $3.59.

The stock is up 135.76% over the past six months and down 32.27% year to date. It sits 62.31% below its 52-week high of US$9.525. Volume was 0.26 times its average.

The Nasdaq Composite is down 0.95% over the past five sessions and up 12.64% year to date.

The company filed an amended quarterly financial report for the period ended June 30, 2026, via EDGAR on Oct. 21, 2026.

Based on public media reports. AI-generated; not investment advice.

Source: Market Movers The copyright of this article belongs to the original author/organization.

The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.

Recommended Readings